A population pharmacokinetic meta-analysis of maraviroc in healthy volunteers and asymptomatic HIV-infected subjects

Author:

Chan Phylinda L. S.,Weatherley Barry,McFadyen Lynn

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference12 articles.

1. The Discovery of the CCR5 Receptor Antagonist, UK-427,857, A New Agent for the Treatment of HIV Infection and AIDS

2. 2B Weatherley, L McFadyen, and P. Milligan, Population analysis of maraviroc phase 1 noncompartmental pharmacokinetic data . In: 15th Meeting of the Population Approach Group Europe. 2006 June 14-16; Brussels, Belgium.

3. 3G Muirhead, A Pozniak, B Gazzard, M Nelson, G Moyle, C Ridgway, R Taylor-Worth, and D Russell . A novel probe drug interaction study to investigate the effect of selected ARV combinations on the pharmacokinetics of a single oral dose of UK-427 857 in HIV+ve subjects (abstract 663) . In: 12th Conference on Retroviruses and Opportunistic Infections. 2005 February 22-25; Boston, MA.

4. SPECIES DIFFERENCES IN THE DISPOSITION OF THE CCR5 ANTAGONIST, UK-427,857, A NEW POTENTIAL TREATMENT FOR HIV

5. A pharmacokinetic-pharmacodynamic disease model to predict in vivo antiviral activity of maraviroc

Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3